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Abstract: Percutaneous vertebroplasty procedure is of major importance, given the significantly
increasing aging population and the higher number of orthopedic procedures related to
vertebral compression fractures. Vertebroplasty is a complex technique involving the injection of
polymethylmethacrylate (PMMA) into the compressed vertebral body for mechanical stabilization
of the fracture. Our understanding and ability to modify these mechanisms through alterations
in cement material is rapidly evolving. However, the rate of cardiac complications secondary to
PMMA injection and subsequent cement leakage has increased with time. The following review
considers the main effects of PMMA bone cement on the heart, and the extent of influence of the
materials on cardiac embolism. Clinically, cement leakage results in life-threatening cardiac injury.
The convolution of this outcome through an appropriate balance of complex material properties is
highlighted via clinical case reports.
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1. Introduction
Approximately 700,000 people suffer from vertebral compression fractures in the United States,
costing over $1 billion for treatment and management [1]. Reinforcement of vertebral compression
fractures with polymethylmethacrylate (PMMA) bone cement through percutaneous vertebroplasty
(PVP) was first introduced by Galibert et al. in 1987 [1,2]. PVP was reportedly not conducted
in the United States until 1994 [3]. It involves injecting PMMA bone cement into the compressed
vertebral body to steady the fracture mechanically [4]. The bone cement popularly used is primarily
a two component system composed of a powder PMMA copolymer and a liquid methylmethacrylate
(MMA) monomer. This is used because it is a bismethacrylate, thus improving network formation
and stability of the cement. The development of this arena has led to many challenges related to the
material properties of PMMA. One other procedure that involves the use of PMMA bone cement
is kyphoplasty, which involves filling of the collapsed or injured vertebra [5,6]. However, the PVP
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technique is much more prone to adverse cement leaks than kyphoplasty, because the PMMA is
injected in a liquid state in the case of PVP and the cement would flow through the bone path of least
resistance [3]. The popularity of the procedure is increasing and it is being used more frequently [7].
PMMA is an inert material which is not reabsorbed in the human body. The polymer achieves
90% of its ultimate strength within one hour of injection [8]. Although alternative materials are available
and continue to be created, PMMA remains the material of choice due to its mechanical properties
and lower rate of professed complications. An overarching problem associated with PMMA is cement
leakage, which may result in both local and global complications [9]. Cement leakage is reported
to be as high as 72.5% in metastases and 65% in osteoporotic fractures [10]. Cement leakage may
cause local complications (cord compression or nerve root compression) or systemic complications
such as pulmonary embolism, cerebral embolism, cardiac embolism, cardiac perforation, renal artery
embolism, and acute respiratory distress syndrome [11]. There is also some unknown long-term result
in the osteoporotic spine. The damage is more prominent in vital organs such as the lungs and the
heart. Even retrograde intra-venous PMMA in femoral nutritional vessels, but without serious side
effects from the heart systems, has been documented [12]. In addition, absorption of the PMMA
monomer can induce hypotension by virtue of its cardiotoxic and arrythmogenic properties [13].
This review will focus on the mechanisms present at the bone cement interface,
related cardiovascular changes in particular, the intra-cardiac embolism, and the various alternatives
and solutions that have been described. The paper will also give the reader an idea about important
publications on bone cement polymer related cardiac emboli.
2. Cement Leakage
One of the significant complications in the reinforcement of vertebral compression fracture is
cement leakage, which flows to the cardiac region (i.e., embolization). Here we describe various
factors that play a role in cement leakage to the heart. Among all the factors, PMMA viscosity is
probably one of the most important determinants dictating cardiac embolism. In addition, advances in
mathematical models related to PMMA cement have been discussed in detail.
2.1. Factors Affecting Cement Leakage
Several factors related to cement leakage include: bone permeability, marrow viscosity,
bone porosity, size of the injection cavity, diameter of the leakage path, bone pore size, and cement
viscosity [15]. Among these factors, the cement viscosity is the only parameter not determined by the
bone structure, indicating that the bone cement leakage can be controlled by adjusting the cement
viscosity. Therefore, PMMA with low and medium viscosity has been identified as an important risk
factor for the development of cement leakage along with bone porosity. High-viscosity PMMA, on the
other hand, effectively stabilizes vertebral compression fractures, while minimizing the risk of cement
leakage and associated complications in vitro [14,15]. Subsequently, decompressed PVP may result
in reduced cement leakage [16]. Nieuwenhuijse et al. performed a detailed analysis of potential risk
factors for the occurrence of cement leakage, and fracture severity and PMMA bone cement viscosity
were identified as two strong independent predictors in general [17]. Lador et al. studied leakage
patterns that understood the points and patterns of cement extravasation in 23 human vertebrae.
This study showed that the most common type of leakage, classified as severe, occured through small
breaches in the cortex due to anterior blood vessels. Severe leakage occurred in 83% of the samples,
and suggested monitoring procedures during injection to avoid complications and to minimize possible
life-threatening risks to the patients [18]. The leakage to the nearby vasculature may reach distant
locations of the body, such as the heart, and result in cardiac embolism [19].
The use of high-viscosity cement seems to stabilize cement flow. However, the forces required
for the high-viscosity cement delivery are significantly higher and may approach or even exceed the
human physical limit of injection forces. Higher injection forces may also result in poor filing of the
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cement [20]. Another possibly detrimental effect due to the use of high-viscosity cement would be the
increase in the extravasation of bone marrow into the cardiovascular system.
2.2. PMMA Viscosity Behavior
Viscosity is probably the most important material property responsible for cement leakage.
An ideal bone cement, when injected, should stabilize vertebral compression fractures. An increase
in the viscosity of PMMA cement is associated with a fast polymerization process. This actively
relates with a higher released temperature and a shorter setting time (Figure 1) [21]. Additionally,
the viscosity steadily increases during the PMMA polymerization process. The storage and loss moduli
also increase over time as the PMMA polymerization progresses [22]. In addition, the bone cement
should be injected at the latest time point possible in order to prevent leakage and extravasation.
This ultimately minimizes the risk of cement leakage and related complications.
Hydrogen peroxide, used as hemostatic agent in arthroplasty, has been shown to adversely affect
the material properties of PMMA [19]. Properties of PMMA cements such as time and shear rate
are essential for examining the cement flow behavior [23]. In addition, a greater chance of embolism
and a reduction in arterial oxygenation resulting in circulatory failure was observed in the use of
hand-mixed PMMA when compared to the use of vacuum-mixed PMMA [24]. It has been further
reported that drilling a hole with and without vacuum can potentially reduce the intraosseous pressure
and, thus, reduce the risk of emboli [22]. Factors such as viscosity, permeability in cancellous bone,
and biomechanical strength of the mixture also play a crucial role [14].
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Figure 1. Depiction of leaked cement mass and time when leakage occurred with elapsed time.
Adapted from [21], with permission from © 2006 Wolters Kluwer Health, Inc..
The rheological properties are important factors influencing the cement flows and they may play
a part in the formation of the p res in the cement du ng polymeriza on. These pores are postulated
to act as sites for initiation of racks wh ch cont bute to the aseptic loosening of the prosthesis [25].
During the bone cement curing, initially the rise in viscosity is largely due to the swelling of the
polymer particles in the monomer, while polymerization of the monomer also contributes and finally
dominates the rise in viscosity at later times, suggesting a strong temperature dependence of the
viscosity-time profiles [26]. Therefore, PMMA bone cement viscosity is not a constant and it has
two different characteristics: (a) rheopectic (where the viscosity rises with time) and (b) pseudoplastic
(where the viscosity drops with shear rate). In order to characterize the time-dependent permeability
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of the bone cement, the time and shear rate dependent viscosity was captured by the following power
law by Baroud et al. [27]:
η =
[
a
(
t
ts
)
+ b
] (
γ
γs
)c(t/ts)+d
(1)
where η is the viscosity, γ is the shear rate, ts and γs are the characteristic time and shear rates,
respectively, and a, b, c, d are the viscosity material parameters. This rheological model of PMMA
bone cements was implemented in ANSYS (Finite Element package) and the agreement between the
analytical and numerical solutions confirmed that the proposed model appropriately captured both
the rheopectic and pseudoplastic behaviors [24]. The finite element analysis indicated a logarithmic
increase of the injection pressure due to the non-uniform viscosity profile in the cannula. It was also
noted that the non-linear increase almost doubled over a period of two minutes. This model could be
further implemented to predict the cement flow behavior.
2.3. PMMA Cement Based Mathematical Model
A theoretical model was proposed by Bohner et al. to analyze the distribution of a PMMA cement
after its injection into a porous structure [28]. The calculations were based on two rheological laws:
the law of Hagen-Poiseuille describing the flow in a cylindrical tube and the law of Darcy describing the
fluid flow through a porous media by assuming that the path of least resistance is cylindrical and that
the cement can only extravasate if it pushes the marrow out of the way when the cement is injected into
an osteoporotic vertebral body. The ratio between the augmentation pressure (the pressure required to
expand the cement spherically) and the extravasation pressure (pressure required to inject the cement
into the path of least resistance) defined as the risk factor for extravasation can be calculated by:
λ =
∆Pa
∆Pe
=
D4e
512pK
f (µc, µm, t, R0, Le) (2)
where De is the diameter of the path of least resistance, p is a dimensionless parameter of the matrix
porosity, K is the matrix permeability, µc is the cement viscosity, µm is the marrow viscosity, R0 is the radius
of the cavity at the injection point, Le is the length of the path of least resistance, and f (µc, µm, t, R0, Le)
is a function of the parameters within the brackets. Extravasation occurs when the risk factor is
larger than 1.
In order to account for the non-Newtonian nature of curing PMMA in a simulation of PMMA
injected through a cannula to improve quantitative accuracy, Lian et al. developed a biochemical model
for PMMA injection by approximating the cancellous bone trabecular network as a branching-pipe
network [29]. The overall pressure drop across the branch segment that is represented as a conical pipe
with radii R1 and R2 at its ends can be derived as [29]:
− ∆P = 8µLQ
pi
[
1
3
(
1
R1R32
+
1
R21R
2
2
+
1
R31R2
)]
(3)
and the effective wall shear-rate magnitude is then
∣∣ .r∣∣wall = 4Q
pi
(√
R1R2
)3 (4)
where Q is the flow rate, µ is the dynamic viscosity of PMMA, R is the cannula radius, and L is the
cannula length.
This computational model approach demonstrated the potential of simulating PMMA injection
into cancellous bone during percutaneous vertebroplasty. This model employed the Hagen–Poiseuille
law to predict the pressure drop across a delivery cannula with viscoelastic changes of curing PMMA
modeled via a time and shear-rate dependent power law. The power law that was derived based on
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dynamic rheological testing of curing PMMA samples was fitted with experimental data. In conjunction
with a branching-pipe geometrical model, the method helped with quick estimation of the overall
injection pressure, and, hence, the reaction force during manual PMMA injection (Table 1). For real-time
simulations, a challenge is to “refresh” (or update) the rendered images and computed forces every
20 and 2 ms for realistic visual and haptic force feedback, respectively [29].
Table 1. Mean ± standard deviations for the measured and calculated parameters: cement viscosity
at injection, injection forces, injection speed, and normalized injection force. Adapted from [7],
with permission from © 2009 Springer.
Differnt Groups Cement Viscosityat Injection (Pa s) Injection Force (N)
Injection Speed
(mm/s)
Normalized Injection
Force (N/Pa mm)
Control group 49.6 ± 13.4 64.6 ± 37.2 6.7 ± 5.4 0.42 ± 0.723
Lavage group 44.6 ± 10.3 54.5 ± 33.9 9.3 ± 3.5 0.16 ± 0.15
Mann-Whitney test/p values 0.401 0.361 0.02 0.73
Homogeneity in control
group/p values 0.00. 0.007 0.12 0.000
Homogeneity in lavage
group/p values 0.737 0.161 0.981 0.000
2.4. Intra-Cardiac Embolism Leading to Cardiovascular Deterioration
Intra-cardiac embolism (ICE) secondary to PMMA leakage could be an incidental finding or it may
appear during the procedure, immediately following the procedure, during hospital recovery, or even
manifest as a long term complication (ranging from days to years) (Table 2, [30–51]). The clinical
significance of cement emboli as an incidental finding on chest radiographs may not be ignored due
to their known long-term sequelae. Early detection and immediate management should be the key
despite the absence of clinical symptoms. When emboli are discovered incidentally on a conventional
chest X-ray, the heterogeneity in shape and pattern make it extremely difficult to arrive at a proper
diagnosis. In such a situation, further evaluation by transthoracic echocardiography, transesophageal
echocardiography, coronary tomography scan, and cardiac magnetic resonance imaging is instrumental
in arriving at the final diagnosis. These diagnostic aids are also helpful in the evaluation of pericardial
effusion and valvular defects. It is extremely important to rule out conditions such as patent foramen
ovale or atrial septal defect (ASD) with the help of a bubble study, as there is a higher probability
of paradoxical embolism related to tiny mobile fragments leading to stroke which may result in the
wrong diagnosis [47].
Adding hydroxyapatite (HA) to PMMA cement to reduce the quantity of barium, which is
used as a radiopacifier, may aggravate cardiovascular deterioration in the event of cement embolism
by the activation of coagulation. Acute cardiovascular consequences of considerable PMMA leaks
(2 mL) may not be severe in persons with a healthy cardiopulmonary system. Subsequent addition
of hydroxyapatite (10%) to PMMA cement did not result in more severe cardiovascular changes [52].
It is possible that thromboembolism may also aggravate cardiovascular deterioration after PMMA
embolism. In addition, it would be impossible to control the quantity of embolized cement [53].
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Table 2. Literature review on Intra Cardiac Emboli (ICE) located in various regions of the heart including the Right Ventricle (RV), Right Atrium (RA), Left Atrium (LA),
and Inferior Vena Cava (IVC).
Caption Procedure Indication Time of Event Symptoms Location of Embolus Treatment Complication
Pannirselvam V Vertebroplasty Multiple myeloma 9 months Syncope RA Medical -
Berthoud B Kyphoplasty Osteolytic Metastasis - - RA - Pericardial Tamponade
Arnáiz-García ME Vertebroplasty Traumatic Vertebralbody fracture During procedure Hypotension, Respiratory distress RV Surgery -
Moon MH Vertebroplasty Compression Fracture 5 years Chest pain, Fever RV Surgery Pericardial Effusion
Gosev Kyphoplasty Compression Fracture 10 days RV - pericardial Effusion
Llanos RA Vertebroplasty Fusion, fracture 2 months Chest pain, dyspnea LA protuding throughatrial septum Surgery -
Tran I BalloonKyphoplasty - 1 day Chest pain, dyspnea RV Snare catheter Pericardial Tamponade
Lee JS Vertebroplasty Compression fracture 6 years Dyspnea RA, RV and the RVoutflow track Medical -
Agko M Kyphoplasty Fusion, Fracture During procedure None IVC Greenfield filter -
Cadeddu C Vertebroplasty Compression fracture 2 years Accidental finding RV, RA - -
Braiteh F Vertebroplasty Compression fracture 5 months Chest pain, Palpitation RV, RA Snare -
Caynak B Vertebroplasty Possible Fracture 2 months Dyspnea Right side(pericaridal space) Surgery Pericardial Tamponade
Son KH Vertebroplasty - 10 days Chest pain, Dyspnea RA, RV, Pericardial space(right side) Surgery
Cardiac perforation,
Triscupid regurgitation
Lim KJ Vertebroplasty Compression fracture 5 years Dyspnea Leg edema RA Surgery -
Lim SH Vertebroplasty
Compression fracture,
Multiple myeloma,
osteolytic metastases
- Chest pain, dyspnea RV Surgery Multiple cardiac perforation
Scroop R Vertebroplasty post-trauma osteoporosis During procedure Hypotension Cerebral Embolism - Patent foramen ovale
Kim SY Vertebroplasty - 7 days Chest pain RA, RV Surgery Cardiac perforation
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3. Alternatives to PMMA
3.1. Calcium Phosphate and Hydroxyapatite
Over time, many varieties of injectable materials have been proposed for use in order to reduce
cement leakages [54]. Calcium phosphate (CP) cement has been used as a clinical substitute to
PMMA. rhBMP-2/CP, an osteoinductive and biodegradable material, is another candidate that may
also be an alternative to PMMA, in order to achieve biostabilization in a vertebroplasty [55]. It has
been demonstrated in animal experiments that fragmentation of calcium phosphate cement yields
more emboli, especially microemboli, resulting in more severe cardiovascular deterioration when
compared to PMMA; this was confirmed by CT scanning of postmortem lungs [56]. Even though CP is
biocompatible, a major drawback is that it rapidly decays when in contact with blood or physiological
fluids. The compressive strength is very similar to PMMA and its isothermic properties during the
setting phase prevents heat related tissue damage [57]. Additionally, it is known that the severity of
pulmonary hypertension after embolism is related to the size and number of emboli [58].
Meanwhile, vertebroplasty with CP yields better clinical and radiological results than conservative
treatments for primary vertebral fractures, with the exception of some intraoperative complications,
such as leakage and embolism [56]. Another concern raised is that the use of self-setting calcium
orthophosphate formulations might aggravate cardiovascular deterioration in the event of pulmonary
cement embolism by stimulating coagulation [57]. One other disadvantage of CP is its poor injectability.
Liquid–solid phase split-up has been noted in commercial formulations [58]. The addition of calcium
phosphate fillers into PMMA bone cement has been reported to be detrimental to cement handling
and mechanical performance [22].
Hydroxyapatite (HA) has been explored as an alternative. The properties of bone conductivity
and the absence of exotherm of hydroxyapatite-forming materials make them an attractive alternative
to PMMA cements [4]. Thus, we believe that the use of HA improved cement is worth it because of its
reduced possibility of causing intra-cardiac and distant embolism when compared to the use of PMMA
cement alone. A paired-design study identified some indirect but mostly insignificant differences in
immediate biomechanical fixation of pedicle screws augmented with the Sr-HA cement compared
with the PMMA cement [66].
3.2. Radio-Opacification
Proper opacification is essential for fluoroscopic monitoring of cement injection to prevent
extravasation and, thus, the potential complication of pulmonary embolism [59,60]. The addition of
nanoparticle radiopacifiers, such as barium sulfate and zirconium dioxide, improve osteoblast adhesion
rather than plain PMMA bone cement. Barium sulfate improves the visibility of the PMMA since it has
a higher atomic number and attenuates the X-rays. Unfortunately, some detrimental effects of these
radiopaque agents on the mechanical behavior of PMMA have been observed [61]. Hernandez et al.
showed that a PMMA cement with 10% w/w barium sulfate has a similar viscosity-time curve,
but a much earlier onset of viscosity rise compared to the same cement with no radiopacifier [62].
This highlights the effect of varying the radiopacifier composition on cement viscosity, and thus the
injection behavior of that cement suspension.
There are adverse effects on injectability, viscosity profile, setting time, mechanical properties of
the cement, and bone resorption. Altogether, radio-opacifiers are considered to be beneficial depending
on their type and concentration. In order to overcome these issues, PMMA microspheres in which
gold particles are embedded and its monomer is the same as that used in commercial cements for
vertebroplasty have been attempted [63].
3.3. Orthocomp™ and Hydroxyapatite
Orthocomp™ is composite material with a matrix of Bis-phenol glycidyl dimethacrylate (BisGMA),
Bis-phenol ethoxy dimethacrylate (BisEMA), and triethyleneglycol dimethacrylate (TEGDMA) [4]. It is
biocompatible, has a lower setting exotherm, and good material properties. In a study comparing
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compressive moduli, Orthocomp™ exhibited a modulus almost twice that of the PMMA cements.
In fact, Jasper et al. suggested that a higher modulus may translate to better mechanical stabilization,
resulting in a lower use of Orthocomp™ compared to PMMA cement [55]. Similarly, for compressive
yield strength and ultimate compressive strength, PMMA cements ranged from 50 ± 73 MPa and from
53 ± 80 MPa, respectively, but Orthocomp™ exhibited strength values 2–3 times those values [64].
3.4. Injection Device and Viscometer
Various optimization tools have also been utilized. The impact of the injection device and
viscometer in controlling cement leakage has been suggested. Gisep’s study showed a strong
correlation of the PMMA viscosity during setting to the injection forces through vertebroplasty injection
devices [67,68]. There was a significant difference in injection forces between the in vitro injections
in room temperature or in a simulated body temperature setting. The viscometer may potentially
have a role in enhancing the safety of percutaneous vertebroplasty procedures. Transpedical body
augmentors have been used to try and prevent body recollapse, as well as PMMA in the short term,
which when used with bone grafts theoretically allows for potential fracture healing in the long term.
3.5. Drug Delivery System, Porous PMMA, and Cementless Procedure
The drug delivery system releasing Vancomycin, an antibiotic, from bone cement is controlled
according to Higuchi’s theory. Imperfect polymerization of the polymer could cause the monomer to
leak and therefore change the matrix structure. Hence, it could affect the release of antibiotics from
bone cement beads. One must prepare cement beads properly, taking into consideration Higuchi’s
equation in order to control release by adjusting the amount of drug in the beads and the diameter of
the cement device [69].
The particle release of porous PMMA cements during curing has been studied, because the release
of powder ingredients obtained from porous PMMA can theoretically cause negative effects such as
embolism. The invention of porous PMMA, in order to make regular PMMA cement more compliant
with cancellous bone, while initially promising, remains questionable [70]. The risk of cement leakage
can also be decreased by using viscoplastic bone cement due to its lower infiltration depth [71].
However, no direct indicators have been identified up to now that can predict cement leakage to prove
superiority of the viscoplastic cement. Further long-term outcome studies comparing cemented to
cementless arthroplasty are still needed [24,36]. The possibility of cementless vertebroplasty remains
unknown. Saleh and his colleagues have indicated cementless fixation may have a positive stint in the
younger population [22].
4. Case Report
PMMA cement cardiac embolism is a potentially serious complication following vertebroplasty
and kyphoplasty. The frequency of pulmonary cement emboli following percutaneous vertebroplasty
varies from 4.6% to 26.9% [72–75]. The risk of ICE remains unknown. ICE may be an isolated finding
or it can co-present with pulmonary emboli. Common chief complaints are chest pain, dyspnea,
and syncope. Presentation may be acute, sub-acute, or chronic. Cardiac perforation, acute valvular
damage, and paradoxical cerebral embolism are the most dreadful complications. Surgery is the
most common management approach. Percutaneous methods involving snaring and the insertion
of an inferior vena cava filter have been successful. Conservative medical therapy has also been
attempted. We present a case of left ventricular PMMA cement emboli via a secundum ASD
causing acute torrential mitral regurgitation (MR). Our anecdotal case illustrates the need for close
monitoring of patients undergoing percutaneous vertebroplasty and kyphoplasty. We also emphasize
the importance of the treatment of any intra-cardiac cement emboli (ICE) because of its capability of
causing serious complications.
A 61-year-old woman with a history of ovarian carcinoma on chemotherapy and vertebral
osteoporotic compression fractures presented with acute onset shortness of breath. She was undergoing
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evaluation for prolonged back pain. Magnetic resonance imaging (MRI) showed compression fractures
at the T11, L1, and L2 vertebrae with no significant retropulsion. In view of her persistent pain and the
failure of conservative management, she underwent vertebroplasty of the T11, L1, and L2 vertebrae
using PMMA cement mixed with barium at an outside hospital. There was a small amount of cement
extravasation into the paraspinal veins and prevertebral veins that was noted during the procedure.
Eight hours after the procedure, the patient complained of shortness of breath. She was intubated
due to profound hypoxia. Chest X-ray and a Computed Tomography (CT) thorax scan showed
multiple dense pulmonary radio-densities along with the presence of cardiac radio-densities (Figure 2).
Transthoracic echocardiography (TTE) and transesophageal echocardiogram (TEE) showed linear,
smooth, elongated wire-like echo-densities in the left ventricle, a secundum ASD, and severe MR with
flail A2 scallop. Fluoroscopy during coronary angiography confirmed the presence of foreign material
in the pulmonary vasculature whose radio-density was identical to the material in the left ventricle.
An intra-aortic balloon pump was also placed. Endovascular retrieval of the cement fragment was
considered. However, given the presence of severe mitral regurgitation, confirmed ASD, and more
than one ICE, the decision was made to approach surgically. The patient was taken to the operating
room. She was placed on cardiopulmonary bypass. An ostium secundum atrial septal defect measuring
1.5 cm in diameter was present. There was severe destruction of the mitral valve apparatus with
rupture of all but one chordae to the anterior mitral leaflet. A few ruptured chordae to the posterior
mitral leaflet were also noted. Under thoracoscopic guidance, the two elongated tan white fragments,
one measuring 3 cm and the other 1.5 cm in length, which were wedged into the trabeculae of the left
ventricle were removed (Figure 3). A 29 mm St. Jude Epic porcine valve was implanted and the ASD
was closed with 3-0 Prolene sutures. No residual MR was noted with intra-operative TEE. Her hospital
stay remained uneventful and she was discharged to a rehabilitation facility after 7 days.
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The frequency of ICE remains unknown. Only a few isolated case reports exist in the literature.
ICE is attributed to the passage of the leaked PMMA from the perivertebral veins into the azygos
vein and then onwards to the inferior vena cava and finally to the right cardiac chambers [30].
In case of the presence of patent foramen ovale (PFO) or ostium secundum atrial septal defect (ASD),
PMMA may cross over to the left atrium and left ventricle and could result in paradoxical embolism.
Llanos et al. reported the cement fragment impacted in the inter-atrial septum and protruded into
the left atrium [32]. We described the presence of PMMA cement in the left ventricular cavity which
embolized through a large ASD and caused the rupture of chordae, consequently resulting in severe
mitral regurgitation. There is one report of tricuspid regurgitation caused by an embolic cement
fragment [32]. Otherwise, there are reviews of cement pulmonary embolism without any reviews
about ICE even though there are a considerable number of instances (Table 2) [30–51].
Some authors have reported the use of a preinjection venogram to decrease the incidence
of pulmonary embolism, and the injection of sclerosing agents into the vertebral body before
vertebroplasty has also been suggested to close venous channels [74–76]. Low viscosity PMMA cement
has also been suggested, but it is not devoid of cardiac embolism. We strongly believe that performing
multiple sitting vertebroplasties can decrease the rate of embolic complications.
The treatment for symptomatic ICE is surgical retrieval. It is extremely useful if the bone cement
is densely adhered to the adjoining cardiac wall or if it is free floating in the pericardial space [30,31].
In the case of cardiac perforation, immediate pericardiocentesis followed by surgery is required.
Valvular conditions associated with cement emboli may require additional valve replacement surgeries
depending on the severity of the regurgitation.
In select cases, percutaneous removal by snare catheter and/or trapping of the embolic fragments
by Greenfield filter [40] (especially in the case of IVC embolus) may be attempted with extreme caution.
More conservative management with anticoagulants should be reserved for peripheral emboli.
5. Conclusions
In this paper, we have reviewed the aspects of PMMA material properties that are relevant to
orthopedic and cardiovascular applications. It is important to note that cement leakage is asymptomatic
in most situations. PMMA viscosity regulated by density and particle size is one of the important
determinants in the formation of the cardiac emboli that may have life threatening implications.
Additionally, avoiding excessive PMMA injection and excessive pressure during injection may
play a role in prevention [11]. Recently, the role of injectable hydrogels has been explored in
vertebroplasty [77]. Future work should attempt to understand its favorable impact on the reduction
of cardiac as well as non-cardiac embolism.
However, despite large investments into engineering research, developments remain limited
mostly as a result of the lack of availability of the perfect candidate for bone cement. Long term
complications can be devastating due to PMMA presence in the coronary arteries or in the chambers of
the heart. The careful evaluation and search for the ideal bone cement systems and methods is crucial
for important orthopedic procedures such as vertebroplasty and kyphoplasties.
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